Zevra Therapeutics, Inc. Capital Lease Obligations, Noncurrent
Zevra Therapeutics, Inc. (ZVRA) had Capital Lease Obligations, Noncurrent of $396.00 thousand as of 2018-12-31, per its 10-K filed 2020-02-28.
Discontinued › Notes › Leases
us-gaap:CapitalLeaseObligationsNoncurrent · last filed 2020-02-28
- 2018-12-31: Capital Lease Obligations, Noncurrent $396.00K.
- 2018-09-30: Capital Lease Obligations, Noncurrent $451.00K.
- 2018-06-30: Capital Lease Obligations, Noncurrent $466.00K.
- 2018-03-31: Capital Lease Obligations, Noncurrent $515.00K.
| Period end | Capital Lease Obligations, Noncurrent |
|---|---|
| 2018-12-31 | $396.00K 10-K · filed 2020-02-28 |
| 2018-09-30 | $451.00K 10-Q · filed 2018-11-09 |
| 2018-06-30 | $466.00K 10-Q · filed 2018-08-10 |
| 2018-03-31 | $515.00K 10-Q · filed 2018-05-11 |
| 2017-12-31 | $562.00K 10-K · filed 2019-03-01 |
| 2016-12-31 | $657.00K 10-K · filed 2018-03-30 |
| 2015-09-30 | $3.00K 10-Q · filed 2015-11-13 |
| 2015-06-30 | $11.00K 10-Q · filed 2015-08-14 |
| 2015-03-31 | $18.00K 10-Q · filed 2015-05-29 |
| 2014-12-31 | $26.00K 10-K · filed 2016-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |